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Abstract
Problem: The Transfemoral Transcatheter Aortic Valve Replacement (TF TAVR) patient
transfer workflow in Hospital K's Cardiac Specialty Unit (CSU) is outdated and not aligned with
current standards employed by other healthcare organizations with TF TAVR programs; for
example, while many other hospitals discharge TF TAVR patients 24 hours post-procedure,
Hospital K's discharge process for its TF TAVR patients is is mostly 48hrs or more. By
following best practices of other healthcare organizations and ensuring no additional
complications from surgery, Hospital K can reduce its TF TAVR patients' Length of Stay (LOS),
lower healthcare costs, and avoid complications associated with an extended hospital stay.
Context: Hospital K is a large, teaching hospital in a highly urbanized region of Northern
California, one of organization AB's two Bay Area primary cardiac hubs. Hospital K's CSU is a
32-bedded high-acuity microsystem staffed with highly qualified RNs well trained to care for
this specific population, typically ranging in age from 55 to 95. The CSU has experienced staff
who favor improvements in inpatient care. Following the lead of other healthcare organizations,
Hospital K can develop interdisciplinary teams, standardize its TF TAVR patient-transfer
workflow and reduce TF TAVR patients' LOS, thereby reducing communication errors between
microsystems, complications associated with LOS and reduce healthcare costs. Integrating a
standardized and streamlined clinical pathway to discharge Hospital K's TF TAVR patients
within 24 hours post-procedure represents an excellent opportunity for the organization's CSU to
lower healthcare costs without sacrificing patient safety and outcomes.
Interventions: The main objective of the project is to standardize the workflow for the TF
TAVR clinical pathway by developing modified screening criteria and streamlined peri- and
post-procedural guidelines. These new criteria and guidelines will be integrated into the clinical
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pathway through staff education, enhanced staffing ratio, and a multidisciplinary team approach
to patient workflow.
Measures: This project's outcome measure is the number of TF TAVR patients included in the
clinical pathway discharged within one day following surgery. The number of patients included
in the pathway but not discharged on a postoperative day one due to atypical complications is the
balancing measure. This project's process measures are 1) staff engagement with the
improvement project and 2) revision of the patient-to-nurse staffing ratio from four-to-one to
three-to-one, which will accommodate the project's higher frequency of clinical assessments per
patient during the immediate post-procedure period.
Results: A total of 148 TF TAVR patients qualified for inclusion in the new pathway. Of those,
84 were discharged postoperative day one. The patients diverted from the new workflow due to
post-procedure conduction delay, bleeding, and hematoma formation at the femoral access site or
hemodynamic instability are transferred to the Cardiovascular Intensive Care Unit (CVICU) for a
higher level of care and observation thus did not discharge per TF TAVR clinical pathway.
Conclusions: Postprocedure next-day discharge following an uncomplicated TF TAVR
procedure is feasible by utilizing a minimalist peri-procedure approach, streamlined transfer
workflow, and a criteria-driven discharge. Organizational protocols, particularly that of the TF
TAVR workflow, should have input from the multidisciplinary heart team to optimize the
discharge process and improve Return on Investment (ROI).
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Restructuring the Transfer Workflow of Transfemoral Transcatheter Aortic Valve Replacement
Patients to Optimize Length of Stay: A Clinical Improvement Project in a Microsystem
Introduction
The evolution of open-heart surgery, particularly in the aortic-valve replacement
procedure, has significantly improved in the last decade as it has become more refined and less
invasive. In August 2019, the Food and Drug Administration (FDA) approved the use of the
Edwards Sapien 3 heart valve system for low and medium risk aortic stenosis patients.
According to Edwards Lifesciences (2019), "PARTNER 3 Trial demonstrated that low-risk
patients treated with the SAPIEN 3 TAVR valve experienced extraordinary outcomes with 1.0
percent rates of death or disabling stroke at one year, a short length of stay and 96 percent
discharged to home or self-care". The FDA approval permitted increased use of this heart valve
device, so heart centers and organizations, particularly Hospital K, have begun using them. In
keeping with Hospital K's priorities of improving inpatient hospital care and reducing costs.
Hospital K joined the PARTNER 3 trial. Hospital K has been leading the way in collaborative
care and plays a vital role in improving customer satisfaction by strengthening its services for
both new and existing patients; however, despite these improvements to customer services,
Hospital K's patient workflow process has not evolved to meet current national standards. The
PARTNER 3 Trial presents an ideal opportunity to study patient workflow processes to identify
opportunities to create more efficiencies and to meet those national standards of best practices.
Therefore, this paper will focus on the patient-transfer process within the current workflow for
TransFemoral Transcatheter Aortic Valve Replacement (TF TAVR) patients to identify critical
problems that, if resolved, will remarkably improve patient outcomes by optimizing patient
workflow and minimizing delays in care. To better understand and improve the patient-transfer
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process, this project incorporates descriptive studies to furnish an up-to-date picture of patient
workflow and services, includes a microsystem analysis done by unit leaders with uppermanagement consultation from Cardiac Service Line leadership for early identification of
problems within the unit affecting productivity and workgroup outcomes, examines the
relationship between microsystems in which the TF TAVR workflow occurs and how that
relationship affects other workplace resources, explores ways to make the TF TAVR program
more efficient and, finally, develops and tests TF TAVR performance measures.
Problem Identification
Organization AB is one of the largest non-profit healthcare organizations in America,
with 21 hospitals dedicated to serving Northern California. It uses an integrated care model that
employs more than 100,000 people across the organization, and more than 11,000 physicians
provide care in its hospitals and clinics. One of these facilities is the cardiac hub for the East Bay
and the greater San Francisco area. Hospital K is a 239-bedded hospital providing a wide variety
of procedures, ranging from the invasive, like open-heart Mitral/Aortic/Tricuspid Valve Repair
or Replacement, to the non-invasive, like the TF TAVR procedures. The core workflow for both
invasive and non-invasive operations have been remarkably successful in terms of patient
turnover rate. The facility accommodates three to eight scheduled operations per day, excluding
emergency procedures, and three to four TF TAVR procedures per week.
However, the current TF TAVR workflow during the transfer process is outdated. The
post-procedure care for the TF TAVR population in Hospital K is done via transfer from the
hybrid Operating Room or Cardiac Catheterization Laboratory to the Cardiovascular Intensive
Care Unit (CVICU). Most of the TF TAVR patients are given conscious sedation or local
anesthesia; thus, they do not require ventilator management. That is, this population has no
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invasive lines (central lines, arterial lines, bladder catheters), which require hemodynamic
monitoring, so the patients are not on inotropic support at all. After completion of the TF TAVR
procedure, most can be managed in the post-anesthesia care unit in keeping with the current
policy and then transferred directly to the medical telemetry floor. Thus, CVICU beds and their
resources are not overutilized, thereby adding an unnecessary burden to the CVICU team and
representing an opportunity to create efficiency in the workflow by eliminating the use of these
beds and their resources.
Improvements in Hospital K's FastTrack TF TAVR workflow should align with the best
practices in clinical pathways followed by other facilities using this process. In most hospitals
that provide the procedure outside organization AB, the median length of stay is only one day for
early discharge because these facilities have developed standardized procedures driven by a
minimalist peri-procedural approach, early post-procedure ambulation, reconditioning, and a
criteria-driven process for patient transfer and discharge. According to Lauck et al. (2016), the
duration of stay for this patient population is an indicator of exceptional care. This improvement
project will utilize the model of the 2014 Vancouver 3M (Multidisciplinary, Multimodality, but
Minimalist) Transcatheter Aortic Valve Replacement Clinical Pathway, which formed an
expanded heart team drawn from the involved microsystems to standardize the workflow of the
TF TAVR program. This report states that the Length of Stay and discharge of TF TAVR
patients depend on multiple factors, including but not limited to 1) eligibility criteria and risk
stratification as determined by the consensus of a multidisciplinary team, including a nurse
program coordinator responsible for conducting a comprehensive physical, mental, and social
functional assessment, and 2) implementing a modified clinical pathway to facilitate a safe
transfer and early discharge. The standardized workflow for the TF TAVR program will be used
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to evaluate care and treatment goals in support of evidence-based practices to improve patient
outcomes while allowing for variations in care, length of stay, and cost of patient care.
Available Knowledge
To support the viability and validity of this improvement project, Hospital K's Financial
Analyst will extract critical data about the organization's cost reductions from the affected
clinical microsystems and the quality improvement group. The data for this improvement project
will be organized and analyzed according to the PICOT question (Population, Intervention,
Comparison, Outcome, and Time). As a result, this project will investigate among the TF TAVR
patients (P), how a stratified post-procedure transfer approach (I) compares to a traditional TF
TAVR transfer pathway (C) and affects the Length of Stay (O) over six months (T).
An electronic search was conducted in the Cochrane Database of Systemic Reviews, the
CINAHL Complete, and the Pub Med databases using combinations of the following keywords:
TF TAVR patients, length of stay, patient screening, discharge process, Post-anesthesia care
unit, cardiac telemetry care unit, discharge clinical pathway, minimalist approach, postprocedure care, and cardiac intensive care unit. Search parameters were set to include English
only research and publication dates no earlier than 2009. The search yielded 153 articles, so the
Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) research evidence appraisal tool
was utilized to evaluate the quality of their evidence and to determine the ten most relevant
studies (see Appendix C for the evaluation table of the studies). From these, three have been
selected for synthesis to provide the framework for the implementation of evidence-based
practices to restructure the transfer process of the TF TAVR population. The three most relevant
studies were Kotronias et al. (2018), Marcantuono et al. (2014), and Lauck et al. (2016). The
JHNEBP appraisal tool ranked these studies at level IA, level IIIA, and level VA, respectively.
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These studies concluded that a risk-stratified, non-invasive, minimalist TF TAVR approach is a
reasonable alternative to the conventional, invasive surgical approach because it presents fewer
complications to patients without compromising safety and efficacy while supporting the
hospital cost-reduction program. The evidence explicitly indicates that the best practice for TF
TAVR patients is to pursue a postoperative one-day standard discharge following 1) a minimalist
approach, 2) standardized post-procedure care, and 3) criteria-driven discharge.
Kotronias et al. (2018) conducted a systematic review and meta-analysis, which
compared the clinical outcomes of TF TAVR patients following the early discharge (ED)
pathway versus standard discharge. The authors concluded that employing a simplified approach
as a routine clinical practice for the ED pathway is as safe as standard discharge in terms of
readmission rates, 30-day mortality, and post-procedure complications requiring permanent
pacemaker implantation.
Marcantuono et al. (2014) revealed additional positive impacts of developing a
standardized clinical pathway to improve outcomes of TF TAVR patients in shortening Length
of Stay (LOS). The researchers developed a Fast Track Protocol (FTP) for TF TAVR patients
and established guidelines to enhance their recovery. The nurses then applied these guidelines to
implement FTP as a clinical pathway for the TF TAVR population. Initiating the FTP enabled
early recognition of TF TAVR patients who were suitable candidates for FTP, resulting in a
higher number of qualified candidates than expected. The patients who completed their clinical
pathway through the FTP shortened their LOS, thereby significantly decreasing hospital costs.
Lauck et al. (2016) conducted the Vancouver TAVR clinical trial to evaluate a
standardized clinical pathway for the TF TAVR population and to facilitate a forty-eight-hour
post-procedure discharge safely. The multidisciplinary TAVR Care Team established protocols
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to standardize care, to identify a subgroup of patients suitable for early release within the fortyeight-hour timeframe, and to decrease LOS for all patients. The multidisciplinary Care Team
utilized risk stratification as eligibility criteria to determine the peri-procedural risk of individual
patients, and it was guided by standardized post-procedure care protocols and uniform criteriadriven discharge procedures. The trial concluded that early identification of pre-procedure TF
TAVR patients who are suitable candidates for FTP is feasible as a method to shorten LOS.
Rationale
Implementing clinical change can be particularly challenging because the comfort and
familiarity of established routines can present barriers. For a planned change to be successful, the
leadership team must engage staff in improving their practice and involve them in sustaining
innovations. The most supported method for introducing a planned change involves a purposeful,
calculated, and collaborative effort (Murphy, 2006). The Nursing and Midwifery Council UK
(2008) suggested that nurses should deliver care using the best available evidence-based
practices and that those practices should be continually updated or improved. To introduce
changes to the TF TAVR transfer process, Lippitt's Phases of Change theory will be used. This
approach focuses more on the nurse leader's roles and responsibilities as a change agent rather
than on the change itself (Kritsonis, 2005). To integrate process improvements within the TF
TAVR transfer process, the nurse leader and affected stakeholders will adhere to Lippitt's seven
steps:
1) identifying inefficiencies in the TF TAVR transfer process and making them known to
staff members of the affected microsystems so that they are aware of the implementation of
planned change.
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2) assessing the motivation and capacity of team members within the microsystem to
execute the planned change and devising a solution to address any barriers that the leadership
team might encounter.
3) evaluating the nurse leader's resources and motivations, including the commitment to
the change, experience in the role, and genuine desire to implement the new transfer process.
4) selecting a progressive change process, including the development of action plans and
strategies whereby deadlines are set, and responsibilities are assigned to members of the affected
microsystems.
5) identifying the nurse leader's appropriate role and developing a clearly defined
understanding of that role by all members of the microsystem to prevent confusion and outlining
each team member's contribution to the TF TAVR transfer process.
6) maintaining the change by streamlining communications among staff members about
the progress of their tasks, processing feedback, and holding regular improvement meetings
among team leaders affected by the planned change to coordinate progress; and lastly
7) gradually discontinuing the helping relationship of the nurse leader by steadily
disengaging that person from the role of change agent without disrupting the change and
undermining the microsystem where the change is made durable by established TF TAVR
transfer process policies and procedures.
Executing these seven steps and monitoring their direct results within the microsystem
are essential responsibilities for the nurse leader in successfully introducing improvements to the
TF TAVR transfer process. Also, staff dynamics and unit characteristics will significantly impact
the success of the improvement project. Hospital K's Medical-Telemetry unit and its staff
members would greatly benefit from the TF TAVR transfer improvement process since it has
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been successfully implemented among other leading cardiac centers in the country and resulted
in improved patient outcomes (White, 2004).
Specific Project Aim
The specific aim of this project is, by June 30, 2020, to reduce the LOS for elective TF
TAVR patients from an average of three days to one day post-procedure by implementing a safe,
evidence-based, standardized, and streamlined transfer workflow and by utilizing a risk-stratified
clinical pathway to evaluate the care and treatment processes so that the TF TAVR transfer
workflow improvement project remains sustainable as practices change and levels of care, LOS
and patient-care costs fluctuate.
Context
This improvement project was initiated in a large, teaching hospital in a highly urbanized
region of Northern California. This facility, Hospital K, is one of organization AB's two Bay
Area primary cardiac hubs. The main objective of the project is to standardize the transfer
workflow for TF TAVR patients. An analysis of the Strengths, Weaknesses, Opportunities, and
Threats (SWOT) of the Cardiac Specialty Unit (CSU) in Hospital K assessed the viability of this
project (see Appendix D). Hospital K's Cardiac Specialty Unit is a 32-bedded high-acuity
microsystem staffed with highly qualified RNs well trained to care for this specific population.
The typical patient in this high-functioning unit ranges in age from 55 to 95. However, the unit
also accommodates congenital heart disease patients who can be as young as in their 20s. The
patients admitted to this unit vary in medical condition but predominantly have heart problems or
are recovering from open-heart surgery. The CSU has high rates of retention for its RN staff.
However, they have varying levels of experience; most have served in the unit for over ten years.
Also, the culture in this unit favorably regards changes to improve inpatient hospital stays. The
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workflow among team members is cohesive, and every team member in the unit is aware of their
specific role and of the expectation that they function as part of the multidisciplinary team. The
high-retention rate, level of experience, attitudes towards improvements in patient care,
knowledge of roles, and expectations among the members of this team all represent strengths
favorable to implementing a structured-change process.
Current patient workflow practices employed by healthcare professionals in the Cardiac
Specialty Unit (CSU) at Hospital K while transferring patients from one microsystem to another
are outdated and not focused on patient-centered care. Currently, TF TAVR patients at Hospital
K move from the operating room to the Intensive-Care Unit for a 24-hour recovery period before
subsequently moving into the CSU. In contrast, other comparable hospitals transfer patients
directly from the hybrid CCL to the PACU then to CSU within procedure day. Hospital K's new
stage of transfer introduces an unnecessary occasion for errors in communications. The Institute
of Medicine's (IOM) landmark report, To Err is Human: Building a Safer Health System (2000),
determined that most medical errors have been associated with ineffective communication
between healthcare microsystems. This description of ineffective communications between
microsystems matches the environment accommodating TF TAVR patients in Hospital K and
represents a weakness in the microsystems providing care for them. Since Hospital K's CSU unit
provides care for the most significant number of patients in the adult services division, its patient
workflow challenges must be addressed to eliminate longstanding gaps in patient care protocols
by standardizing the TF TAVR workflow to reduce patients' LOS and to improve their outcomes.
Since the failure or success of significant improvement projects is often attributed to the
dynamics of the healthcare professionals working within specific microsystems, empowering
these frontline professionals with knowledge of the organization's goals and with recognition
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from management of their important role linking the organization to the customer will enable
them to achieve their performance goals and targets (Likosky, 2014). This strategy represents an
opportunity to strengthen Hospital K's communications weakness.
The microsystems relevant to TF TAVR patients at Hospital K often lack such
interdisciplinary collaboration, and this weakness threatens Hospital K's standards for patient
care. The creation of dynamic, interdisciplinary teams among hospital microsystems can improve
communications among team members and thus improve patient outcomes (Bender, Connelly,
Brown, 2012). To prevent undesirable results from Hospital K's lack of collaboration, engaging
in a structured-change process among multidisciplinary teams will provide an opportunity to
strengthen the weaknesses in collaboration among its microsystems. To ensure safe and efficient
implementation of a new transfer workflow, budgetary analysis showing how streamlining the
transfer process will reduce costs and improve the Hospital K's Return on Investment (ROI) has
been presented to stakeholders. For example, Financial Statistics (FinStat) shows that, from
January 2020 to June 2020, the average Cost Per Patient Per Day (CPPD) in the CVICU is
$4,897.30 compared to the CSU's CPPD of $1,805.99—eliminating the CVICU stage of care
would save each patient $4,897.30. About 100 TF TAVR patients have been included in the new,
streamlined patient transfer process implemented at Hospital K since January 2020, representing
a total cost reduction of $489,730.00. Although the cost of training 80 staff nurses over four
hours at about $100/hour required a $32,000 expenditure, the total cost of integrating the new
transfer process is still less than the CVICU's annual CPPD and is in compliance with this
project's focus on patient satisfaction, reduced LOS and cost-saving measures; it thus represents
a significant value for the stakeholders (see Appendix E for cost-benefit analysis).
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Intervention
This improvement project focused on standardizing the TF TAVR workflow in the CSU
by applying a Plan, Do, Study, Act (PDSA) structure to enable earlier patient recovery, reduced
LOS, and earlier patient discharge (See Appendix F for the PDSA Cycle). As an improvement
intervention, nurse leaders and members of the cardiac service line developed a standardized
transfer workflow to optimize the LOS of the TF TAVR population by:
Planning: Formulating a patient-specific transfer workflow for Hospital K's CSU staff to
follow when caring for TF TAVR patients;
Doing: Using the cardiac service line members, Hospital-Based Practices (HBPs) and the
nurse leadership team to educate Hospital K's CSU staff on their educational days to develop the
skill competencies to follow the evidence-based practices utilized by other high performing
cardiac organizations—on their educational days, participating staff "shadowed" members of the
CVICU, observed the workflow that they will follow in the CSU unit, and performed a return
demonstration in the Cardiac Procedural Unit (CPU) regarding the removal of the radial artery
compression device or TR band with experienced frontline staff to standardize the practice and
consistently adhere to patient-specific guidelines;
Studying: soliciting support from Hospital K's administrative leadership to approve an
enhanced staffing ratio of 3 is to 1 during TF TAVR days and a cut-off time of 2:00 pm for
accepting patients into the CSU to enable the CSU staff to understand the new workflow and
present feedback to management on significant observations;
Acting: Integrating the structured-change improvement procedures within the regular TF
TAVR patient workflow in Hospital K's CSU.
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Throughout this improvement project, open communication among affected stakeholders
was essential for its success. As staff members were re-educated about the new standardized care
procedures and as the multidisciplinary team incorporated their improved processes into the new
workflow, ongoing communications were critical for diminishing skepticism and mistrust within
the system.
Study of the Intervention
Hospital K's TF TAVR program in the CSU was generated from multiple evidence-based
studies presented by the Cardiac Service Line team. For example, the Vancouver Minimalist
Clinical Care Pathway or 3M TAVR study was adopted as a model for improving the existing
workflow (see Appendix F for this transfer pathway). The microsystem was assessed in early
October 2019 to develop a baseline consensus from staff about the new workflow. The workflow
was presented and discussed during the CSU monthly meeting and daily staffing huddle as a test
of change. After the frontline staff expressed a definite consensus about the improved workflow,
broader staff education and further training sessions were carried out in December 2019. Eighty
percent of CSU staff attended an educational session. With this overwhelming turnout,
experienced cardiac procedural staff provided a skill simulation regarding groin management,
TR band removal, TF TAVR patient-specific assessments, and handoff communications between
HBS, cardiac nurse practitioners, and cardiac procedural interventionists—these communications
also include the CVICU intensivist regarding any significant change in patient status
necessitating a higher level of care. Before the 'Go-Live" date of January 2020, the nursing staff
was encouraged to voice any concerns about the workflow and to provide inputs to improve the
CSU pathway; these included the patient-to-staff ratio and how to adjust staffing on TF TAVR
procedure days, especially during the most vulnerable stage of patient recovery. Stakeholders
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approved an enhanced patient-to-staff ratio of three is to one, cementing the forward movement.
During the first week of implementation, the process went smoothly, with TF TAVR patients
undergoing the new transfer workflow. This test case proved to be a significant success for the
entire cardiac line and staff because the improved process turned out to be reliable and resulted
in an excellent patient outcome.
This improvement project was evaluated through clinical audits of patients' Electronic
Health Records (EHR) on patient outcomes. The action plan was assessed to determine the
project's reliability and validity. Hospital K's financial analyst and quality improvement team
generated data via patient charts to validate the success of the improvement project. Monthly
meetings with stakeholders took place every third Tuesday of the month to provide significant
input to support the project's sustainability, thus improving staff communications and promoting
patient safety. Consistent measurements allowed the Clinical Nurse Leader (CNL) to make
comparisons across the affected microsystems to determine the project's effect on patient
outcomes. To respond to variables requiring quick attention, the CNL included the frontline staff
who can readily identify existing barriers to the improvement project. While planned changes are
vulnerable to failure, careful consideration of the integration of the change theory can streamline
the process for the CNL and support members of the microsystems so that they will be more
receptive to it (Mitchell, 2013).
Measures
The outcome measure utilized for the project is the percentage of TF TAVR patients who
over six months, initially met the criteria for inclusion in the TF TAVR pathway and are
discharged at postoperative day one after undergoing their procedure. The process measure
would be the following: the percentage of staff who are engaged in the structured-change
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process, provided with classes and provided with hands-on clinical skills training specifically for
the TF TAVR pathway; and enhancing the nursing ratio of one nurse for every three patients on
TF TAVR procedural days, which are Tuesday, Fridays, and every other Thursday. Lastly, the
percentage of patients that are included in the TF TAVR pathway but did not discharge on a
postoperative day one would be the balancing measure for this improvement project. The
Clinical Nurse Leader (CNL) will provide oversight, analysis, and validation of the variables.
The CNL has the necessary tools to implement this improvement process in keeping with current
healthcare best practices and standards of care. (See Figure 1 below for the project result).
Ethical Consideration
The focus of this study is to improve patient outcomes by revising and updating the
clinical transfer workflow of the TF TAVR population. Lowering healthcare costs and improving
patient healthcare outcomes is one of the main objectives for implementing this improvement
project. There were no ethical implications or conflicts of interest significantly affecting patient
care delivery when the project was started. This project has been approved as a quality
improvement project by the University of San Francisco Nursing faculty using Quality
Improvement Review guidelines. It does not require Institutional Review Board approval.
Results
Since project implementation in January 2020, a total of 148 TF TAVR patients qualified
for inclusion in the new pathway. Of those, 84 participants were discharged postoperative day
one (see Appendix H for project improvement tools). According to this measure, the project
succeeded beyond expectations, considering the massive scope of this project and the difficulties
of changing nursing practices in a labor-union environment. Initially, CSU staff resisted the
change, and the California Nurses Association union representative issued a cease-and-desist
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order demanding that the project not be implemented. However, the CSU Nurse Leaders sought
staff nurses' input to alleviate their fears and also provided support for the staff, the medical
team, and other stakeholders to encourage project acceptance and to promote positive changes.
Chart-audit review revealed a few significant deviations from the new patient workflow
during the transfer to CSU, including post-procedure conduction delay, bleeding, hematoma
from the groin access site, and hemodynamic instability, all prompting transfer of the patient to
the CVICU for a higher level of care and more frequent observation. This group of patients that
were transferred to CVICU and was deferred from the pathway did not discharge the next day.
Figure 1: Number of the TF TAVR procedure per month. 40% is the set goal.
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Summary
This quality improvement project has enabled Hospital K to lower healthcare costs
without sacrificing patient quality outcomes and satisfaction scores. The project addresses
national patient safety initiatives and goals that focus on process improvements; it also embraces
all aspects of the Institute of Healthcare Improvement (IHI) Quadruple Aim. The IHI design
optimizes healthcare system performance by enhancing patient experience, reducing healthcare
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costs, improving patient outcomes, and ensuring staff satisfaction. Of note, the specific aim of
this project is to reduce the LOS of TAVR patients from three days to one day postoperatively.
Currently, TF TAVR interventions have three or four patients allotted for the pathway during
procedural days; every other Thursday has been added to accommodate an increase in the
number of mild, moderate, and severe risk aortic stenosis patients utilizing the TF TAVR
procedure now included in the improved pathway. Also, the 2:00 pm cut-off time has been
eliminated by hiring an additional HBS team member dedicated to this clinical pathway.
Nonetheless, continuous evaluation by the leadership team for any significant quality gap within
the project remains the highest priority.
In addition, the current COVID 19 pandemic has arisen as a new threat to Hospital K's
TF TAVR workflow because cardiac patients nationwide are not reporting to emergency rooms
or seeking care at the same rates as they did before the pandemic impacted hospital care. To
maximize bed capacity for potential COVID 19 patients, Hospital K had eliminated all nonCOVID-related care; however, in mid-May 2020, Hospital K has resumed receiving non-COVID
patients. Nevertheless, TF TAVR patients themselves are still avoiding hospital admission for
fear of acquiring the dreaded virus. The new streamlined patient-transfer procedure, which
shortens LOS in the Hospital and eliminates care in the CVICU, can mitigate these concerns
because it removes any exposure to staff and patients in that unit, along with the possibility of
patient exposure to the virus from that vector.
Conclusion
This structured transfer process for the TF TAVR clinical pathway in Hospital K supports
its goal of providing patient-centered care that utilizes a safe, early patient recovery and
standardized post-procedure care. However, it is achievable only if affected microsystems
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support in improving the workflow process to benefit the patient and the organization.
Specifically, staff engagement in the transfer improvement project is a significant factor in
determining whether the improved TF TAVR pathway succeeds or fails because, if the staff are
not fully confident in their ability to provide care for such a heterogeneous group of patients, the
project will fail even before it launches. The project also fosters progress in the nursing
profession by investing in knowledge acquisition and skills for practice change and improved
outcomes. As pat of Hospital K's sustainability project, the leadership team must consistently
provide clinical support to provide confidence in the affected microsystem staff. To sustain the
upward traction of the project and maintain its positive output to the organization, staff
competency must be maintained through training and education initiatives and practice standards
since staff involvement is one of the core measures of this improvement project.
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Appendix A
IRB Non-research determination form
CNL Project: Statement of Non-Research Determination Form
Student Name: Christina M Mangyao

Title of Project:
Restructuring the Transfer Workflow of Transfemoral Transcatheter Aortic Valve Replacement
(TF TAVR) Patients to Optimize Length of Stay
Brief Description of Project:
A) Aim Statement:
Global Aim: To create and implement a safe, standardized, and streamlined transfer
workflow for elective TF TAVR patients, thereby enhancing the patient's length of stay to promote
for next-day discharge
Specific Aim: The specific aim of this project is, by June 30, 2020, to reduce the LOS for
elective TF TAVR patients from an average of 3 days to 1 day post-procedure by generating and
implementing a research-based, safe, standardized, streamlined and restructured transfer workflow.
B) Description of Intervention: Intervention for the project would be based on a minimalist
procedure approach, standardized clinical pathway on affected microsystem, and systematic
discharge criteria to ensure that a safe next-day discharge is achieved. A multidisciplinary team
safety assessment is included in the pathway to ensure that quality outcomes and goals are met.
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C) How will this intervention change practice? The intervention would minimize patient
transfer by eliminating TF TAVR patients from transferring into the Cardiovascular Intensive Care
Unit (CVICU) post-procedure as the interventional approach is aim towards the minimally
invasive procedure. A post-procedure stay would be in the Post Anesthesia Care Unit (PACU) to a
maximum of two hours and post PACU transfer to the Cardiac Specialty Unit within procedure
day to ensure a safe and positive next-day discharge.
D) Outcome measurements
Measures:

Outcome Measures

Data Source

Target

Percentage of patients who meet the inclusion

Chart documentation

40%

Staff engagement for the new process by

Attendance Report

80%

providing classes and hands-on clinical skills

Return Demonstration

criteria for the TF TAVR pathway are
discharged at 24 hours
Process Measures

specific for the TF TAVR pathway
The nursing staff to patient ratio of 3 is to 1
during TF TAVR procedural days ( Tuesday,
Friday, and every other Thursday).

Staffing

80%
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Balancing Measures
Patients included in the clinical pathway but are

Chart Documentation

60%

unable to discharge 24hrs post-procedure

To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the
criteria outlined in federal guidelines will be used:
(http://answers.hhs.gov/ohrp/categories/1569)

☐ This project meets the guidelines for an Evidence-based Change in Practice Project, as

outlined in the Project Checklist (attached). The student may proceed with implementation.

☐This project involves research with human subjects and must be submitted for IRB approval
before project activity can commence.
Comments:
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EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST *
Instructions: Answer YES or NO to each of the following statements:
Project Title:
The project aims to improve the process or delivery of care with established/
accepted standards or to implement evidence-based change. There is no intention
of using the data for research purposes.
The specific aim is to improve performance on a specific service or program and is
a part of usual care. ALL participants will receive a standard of care.
The project is NOT designed to follow a research design, e.g., hypothesis testing
or group comparison, randomization, control groups, prospective comparison
groups, cross-sectional, case-control). The project does NOT follow a protocol that
overrides clinical decision-making.
The project involves the implementation of established and tested quality standards
and/or systematic monitoring, assessment, or evaluation of the organization to
ensure that existing quality standards are being met. The project does NOT
develop paradigms or untested methods or new, untested standards.
The project involves the implementation of care practices and interventions that are
consensus-based or evidence-based. The project does NOT seek to test an
intervention that is beyond current science and experience.
The project is conducted by staff where the project will take place and involves
staff who are working at an agency that has an agreement with USF SONHP.
The project has NO funding from federal agencies or research-focused
organizations and is not receiving funding for implementation research.
The agency or clinical practice unit agrees that this is a project that will be
implemented to improve the process or delivery of care, i.e., not a personal
research project that is dependent upon the voluntary participation of colleagues,
students, and/ or patients.
If there is an intent to or possibility of publishing your work, you and supervising
faculty and the agency oversight committee are comfortable with the following
statement in your methods section: "This project was undertaken as an Evidencebased change of practice project at X hospital or agency and as such was not
formally supervised by the Institutional Review Board."

YES

NO














ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an
Evidence-based activity that does NOT meet the definition of research. IRB review is not
required. Keep a copy of this checklist in your files. If the answer to ANY of these questions
is NO, you must submit for IRB approval.
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human
Research Committee, Partners Health System, Boston, MA.
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Project Charter: Restructuring the Transfer Workflow of Transfemoral Transcatheter Aortic
Valve Replacement (TF TAVR) Patients to Optimize Length of Stay
Global Aim:
To create and implement a patient-specific guideline in the transfer workflow of the TF TAVR
population, thereby reducing the length of hospital stay.
Specific Aim:
By restructuring the transfer process, the TF TAVR patients included in the clinical pathway will
reduce their length of stay (LOS) from an average of three days to one day by June 30, 2020.
Background:
The evolution of open-heart surgery, particularly in aortic valve replacement procedure, has
significantly improved in the last decade. The method has become more refined and less
invasive. In August 2019, the Food and Drug Administration (FDA) had approved the use of the
Edwards Sapien 3 heart valve system for low and medium risk aortic stenosis patients. The
approval marked a significant improvement in the utilization of the heart valve device. Heart
centers and organizations, particularly in Hospital K, have begun utilizing such device upgrades.
However, the current patient workflow process has remained the same and has not evolved into
the current national standards. This paper will describe the current workflow of TF TAVR
patients and it will identify critical issues that will remarkably improve patient workflow and
minimize delays in care. To better understand the transfer process, suggestions have been
provided such as utilizing descriptive studies to furnish an up-to-date picture of current patient
workflow and services; microsystem analysis to be done by unit leaders with upper management
consultation for early identification of unit problem: effects on outcomes, such as productivity
and workgroup outcomes; examination of the relationship between microsystems where the TF
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TAVR workflow takes place and other workplace resources; further examination of influences
on the TF TAVR utilization program; and development and testing of the TF TAVR
performance measures. This improvement project aims to focus on the role of the Clinical Nurse
Leader in improving the transfer process of TF TAVR patients from the previous patient transfer
workflow. Instead, the goal is to integrate a new transfer process that focuses on producing
positive patient outcomes by reducing inpatient stay, increasing patient and family satisfaction,
and lowering healthcare costs. The Clinical Nurse Leader (CNL) has the necessary tools to
implement this improvement process to align with current healthcare practice and standards of
care.
Sponsors:
Bridget Williams, RN, MSN, Chief Nurse Executive
Judy Kornell, RN, MSN, MBA, CCRN-K, Adult Service Director
Gilbert Young, RN, MSN-CNL, Nurse Manager
Lance M Retherford, MD Chief of CardioVascular (CV) Anesthesia
Lorna Thompson, MD CV Hospital Base Services
Jacob Mishell, MD Structural Heart Program Director
Sonja Jung, RN, NP Structural Heart Clinic Director
Kelsey R Fisher, Financial Analyst
Kelly McDonnell, Team Lead, Quality Improvement Group
Team:
Christina Mangyao, BSN, RN, Assistant Nurse Manager
Jeanne Ebuen, RN, MSN, Assistant Nurse Manager
Rheo Rhen Ortega, RN, Assistant Nurse Manager
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Catherine Toscano, BSN, RN, Assistant Nurse Manager
Cardiac Specialty Unit staff members
Post-Anesthesia Care Unit staff members
Goals:
To provide a standardized and enhanced transfer workflow of elective TF TAVR patients by
using a streamlined phase of care transfer criteria adjusted to the affected multidisciplinary team
by:
1. Modifying the current workflow process and improving communication strategy from affected
units utilizing the new TF TAVR pathway.
2. Setting new criteria for patient inclusion and exclusion for the TF TAVR transfer pathway as
guided by the cardiac medical team and the safety of patient transfer.
3. Time target inclusion between the transfer process from the Post Anesthesia Care Unit
(PACU) to the Cardiac Specialty Unit (CSU).
4. Optimizing clinical measures and guidelines for a safe early discharge for patients approved
for the TF TAVR pathway from 3 days to a day.
Measures:
Outcome Measures

Data Source

Target

Percentage of patients who meet the inclusion
criteria for the TF TAVR pathway are
discharged at 24 hours
Process Measures

Chart documentation

40%

Staff engagement for the new process by
providing classes and hands-on clinical skills
specific for the TF TAVR pathway
The nursing staff to patient ratio of 3 is to 1
during TF TAVR procedural days ( Tuesday,
Friday, and every other Thursday).

Attendance Report
Return
Demonstration
Staffing

80%
80%
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Balancing Measures
Patients included in the clinical pathway but are
unable to discharge 24hrs post-procedure

Chart
Documentation

60%

Measurement Strategy
Background (Global Aim)
To create and implement a patient-specific guideline in the transfer workflow of TF TAVR
patients, thereby reducing the length of hospital stay and safe next-day discharge by June 2020 in
the CSU.
Population Criteria:
Elective TF TAVR patients admitted for the clinical pathway from January 2020 to June 2020.
Data Collection Method:
Data collection will be obtained through chart documentation via electronic health records
(EHR) by members of the multidisciplinary team, providing care for this population of patients.
The baseline sample would be 100 elective TF TAVR patients. The report will include the
percentage of the patients that satisfactorily transferred to the CSU within the allotted time and is
safely discharged on a postoperative day one.
Data Definitions
Data Element

Definition

Audit reports

Reports that are generated from data collected
and reported by affected microsystems.

TF TAVR pathway

Patients that are included in the enhance
transfer and discharge process.

Staff meeting

Staff attendance score of 80% and above
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The process to minimize the length of hospital
stay by revising the inclusion criteria in the
TF TAVR pathway.

Measure Description
Measure
Percentage of staff engagement

Percentage of patients that are included
in the TF TAVR pathway and discharge
postoperative day one

Percentage of patients that are included
in the TF TAVR pathway and did not
discharge postoperative day one

Measure Definition
N= total nurse population in
the CSU.
D= Total Number of CSU
staff who attended the
training
N= Number of TF TAVR
patients included in the
pathway
D=Number of patients
discharged on postoperative
day one
N= Number of Tf TAVR
patients included in the
pathway
D=Number of patients that
did not discharge post
operative day one

Data source
Attendance
Report

Goal
80%

EHR audit

100%

EHR audit

100%
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Driver Diagram:

AIM

The specif aim of
the project is to
restructure the
transfer process,
thereby TF TAVR
patients included
in the clinical
pathway will
reduce their length
of stay (LOS) from
an average of three
days to one day by
June 30, 2020.

PRIMARY

SECONDARY

DRIVERS

DRIVERS

Staff Engagement

Educate on the
benefits with
evidence practice
literature review,
significant data, and
process change

Standardized patient
workflow specific to
the unit

Measure Outcomes

Patient satisfaction
scores and patient
care experience,
patient centered care
and patient safety
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Changes to test
Hospital K's TF TAVR program in the CSU is generated from the multiple evidencebased works of literature that were presented by the Cardiac Service Line team. The Vancouver
Minimalist Clinical Care Pathway or 3M TAVR study was adopted to revised the previous
workflow (see Appendix1a for the transfer pathway). Microsystem assessment was done in early
October 2019 to create a baseline consensus from staff on the new workflow. This was presented
and discussed during the CSU monthly meeting and daily staffing huddle as a test of change.
After a positive consensus from frontline staff about the improved workflow, staff education and
training sessions were carried out in December 2019. Eighty percent of CSU staff attended the
educational session. After an overwhelming staff turnout, skill simulation was provided by
experienced cardiac procedural staff about groin management, TR band removal, patient
assessment specific for the TF TAVR patients, and handoff communication workflow between
HBS, cardiac nurse practitioners, and cardiac procedural interventionalist. The CVICU
intensivist is also included in the communication loop for any significant change in the patient
status requiring a higher level of care. Before the 'Go-Live" date of January 2020, staff were
encouraged to voice any concerns about the workflow and motivated to provide unit inputs that
can be included in the pathway that is specific for the CSU. Most concerns were staffing ratio
and how to adjust staffing, especially during the most vulnerable stage of the patient recovery,
during TF TAVR procedure days. Stakeholders approval for the enhanced patient to staff ratio of
3 is to 1 cemented the forward movement of the plan change. During the first week of the
implementation, the process went accordingly with one TF TAVR patient admitted using the
transfer workflow. It was a significant success for the entire cardiac line and staff that such
process improvement is reliable and offered an excellent patient outcome.
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This improvement project was evaluated through clinical audits via patients' Electronic
Health Records (EHR) on patient outcomes. The effectiveness of the action plan will address the
reliability and validity of the project. The financial analyst and quality improvement team
generated data via patient charts to validate the success of the improvement project. Monthly
meetings with stakeholders are arranged every third Tuesday of the month to provide significant
input to support the sustainability of the project, thus improving staff communication and
promote patient safety. Using consistent measurements will allow the Clinical Nurse Leader
(CNL) to make comparisons across the affected microsystems to determine the effect on patient
outcomes. To respond to variations that need quick attention and action, the CNL will include
the frontline staff who can readily identify existing barriers to the improvement project. While
planned changes are vulnerable to failure, careful consideration of the integration of the change
theory can streamline the process for the CNL and support members of the microsystems so that
they will be more receptive to it (Mitchell, 2013).
CNL Competencies
The role of the Clinical Nurse Leader (CNL) in integrating an updated TF TAVR clinical
pathway at Kaiser Permanente is to lead and implement a collaborative approach within the
interdisciplinary team. The new integration of care will require the CNL to apply evidence-based
practices to assess the quality of care delivered by affected microsystems and to lead quality
improvement processes. The CNL will need to drive and sustain an interdisciplinary approach
that will ensure the delivery of safe and comprehensive care, efficiently integrate care services
across multidisciplinary teams, and be cost-effective to the organization. According to PorterO'Grady, Clark, and Wiggins (2010), leadership starting at the microsystem is necessary to
redesign healthcare structures effectively. The CNL must understand the complexities of
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each microsystem and the work culture of frontline staff. The CNL should possess the
knowledge and skills to deploy the most useful resources to ensure the best patient outcomes.
Because the initial costs of integrating the improved patient-transfer process will rise,
the CNL must also generate support from stakeholders by explaining how the long-term costs
will decrease and ultimately improve the organization's overall budgetary portfolio. Investing in
the transformational leadership role of the CNL is an essential factor in implementing
innovations since the team members feel trust in their leader. Hence, the team members are
motivated, and they are more aware of the importance of the outcomes in the improvement of
patient care. (deCasterlé, Willemse, Vershueren, Milisen, 2008).
Lessons Learned
Staff Engagement in the transfer improvement project is a significant factor in
determining the TF TAVR pathway would be successful or a failure. If the staff are not fully
confident in their skills to provide care for such a heterogeneous group of patients, the project
would not take-off even before it starts. The leadership team should consistently provide clinical
support and have trained superusers to provide confidence to the affected microsystem staff. The
need for team collaboration among the medical and nursing staff would significantly enhance the
successful implementation of the process change.
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Project Timeline
Dates
Define Project
and Aim
Microsystem
Assessment
Literature
Search
Meet with staff
for consensus
on the plan
change
Staff education
and training
Go live date
with clinical
staff
Monthly
cardiac
meeting for
process
improvements
Post
implementation
staff survey at
first month and
data analysis
Post
implementation
staff survey at
1st quarter.
Staff meeting
to assess if
changes are
needed
Staff updated
on increase in
case capacity
and workload

Aug
2019

Oct
2019

Dec
2019

Jan
2020

Feb
2020

Mar
2020

Apr
20020

May
2020

June
2020
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Appendix C
Evaluation Table
PICOT Question: In TransFemoral (TF) Transcatheter Aortic Valve Replacement (TAVR)
patients (P), how does a systematic, post-procedure transfer approach (I), compare to a
traditional TF TAVR transfer approach (C), affect the length of stay (LOS) (O) over six months
(T)?
Study
Design
Sample
Outcome/
Evidence
Feasibility
Rating
Kotronias, R. A., Teitelbaum,
M., Webb, J. G., Mylotte, D.,
Barbanti, M., Wood, D. A.,
Bagur, R. (2018, September 10).
Early versus standard discharge
after transcatheter aortic valve
replacement: A systematic
review and meta-analysis.
JACC: Cardiovascular
Interventions, 11(17), 1759-71.
http://dx.doi.org/https://doi.org/1
0.1016/j.jcin.2018.04.042

Systematic
Review with
Meta-Analysis

Eight studies
that include
1,775
participants that
meet the
inclusion
criteria for TF
TAVR fast
track discharge.

Useful in providing
relevant data on how
achievable a one-day
discharge process is if
specific benchmarks are
modified or simplified to
provide a safe transfer
process.

Level I
A

Lauck, S. B., Wood, D. A.,
Baumbusch, J., Kwon, J., Stub,
D., Achtem, L., Webb, J. G.
(2016, April 26). Vancouver
transcatheter aortic valve
replacement clinical pathway:
Minimalist approach
standardized care and discharge
criteria to reduced length of
stay. Circulation:
Cardiovascular Quality and
Outcomes, 9(3), 312-21.
http://dx.doi.org/DOI10.1161/cir
coutcomes.115.002541

Quality
Improvement

Three hundred
ninety-three
patients that
underwent TF
TAVR between
May 2012 and
October 2014 in
a heart center in
Vancouver,
Canada.

Early discharge and
Level V
shorter LOS can be
A
achieved by implementing
a pre-procedure risk
stratification plan, early
mobilization in postprocedure care, and
reconditioning. A
multidisciplinary team and
stakeholder
involvement in adapting
these advances have
improved patient
outcomes and reduced
overall healthcare costs.
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Lauck, S. B., Sathananthan, J.,
Park, J., Achtem, L., Smith, A.,
Keegan, P.,Wood, D. A. (2019,
November 12). Post-procedure
protocol to facilitate next-day
discharge: Results of the
multidisciplinary multimodality
but minimalist TAVR
study. Catheter Cardiovascular
Intervention, 1-9.
http://dx.doi.org/https://doi.org/1
0.1002/ccd.28617

Case Report

Four hundred
eleven
participants in
13 North
American
Centers from
2015 to 2017

Implementation of a
Level V
standardized, minimalist
A
approach, along with a
nurse-lead post-procedural
protocol, has resulted in a
safe and optimal next-day
discharge with a lower 30
days readmission risk.

Marcantuono, R., Gutsche, J.,
Burke-Julien, M., Anwaruddin,
S., Augoustides, J. G., Jones, D.,
Herrmann, H. C. (2014,
November 20). Rationale
development implementation
and initial results of a fast track
protocol for transfemoral
transcatheter aortic valve
replacement. Catheterization
and Cardiovascular
Interventions, 85(4), 648-654.
http://dx.doi.org/DOI:
10.1002/ccd.25749

DescriptiveRetrospective
study

Patients who completed
Level III
the FT pathway
A
experienced a shorter LOS
and fewer direct costs as
compared to those who
deviated or were ineligible
for the pathway.

Rathore, S., Latyshev, Y.,
Emore, S., Rowe, J., & Foerst, J.
(2017, December). Safety
predictors of next-day discharge
after elective transfemoral
transcatheter aortic valve
replacement. Cardiovascular
Revascularization
Medicine, 18(8), 583-587.
http://dx.doi.org/https://doi.org/1
0.1016/j.carrev.2017.05.014

DescriptiveRetrospective
study

Ninety-nine
patients
underwent TF
TAVR from
June 2013 to
December 2013
in two
Pennsylvania,
Philadelphia
heart
institutions.
Eighty-seven of
the studied
population
completed the
pathway.
100 elective TF
TAVR cases
from January
2014 to
December 2015
at heart institute
in Roanoke, VA

The development of a fast Level III
track protocol has been
B
described to reduce LOS
and decrease overall
procedure cost. Next-day
discharge is safe and
achievable in
uncomplicated elective TF
TAVR. If procedural
changes and a minimalist
approach is implemented
to simplify care, then next
day discharge is
permissible.
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Chopra, M., Luk, N. H., Backer,
O. D., & Sondergaard, L. (2018,
December 10). Simplification
and optimization of transcatheter
aortic valve implantation- fast
track course without
compromising safety and
efficacy. BMC Cardiovascular
Disorder, 18(281), 1-9.
http://dx.doi.org/https://doi.org/1
0.1186/s12872-018-0976-0

Case Report

None
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Adopting a minimalist
Level V
procedure and optimizing B
care to decrease LOS have
shown a marked
advantage over the
traditional approach
without compromising
patient safety and clinical
outcomes.
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SWOT Analysis
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Appendix E
Cost-Benefit Analysis
TF TAVR Cost-Benefit Analysis from January 2020 to June 2020 between CVICU
admission and CSU admission:
Source: FinStat

Total TF TAVR
Cases in 6 Months
184

CVICU CPPD
$4,897.30

CSU CPPD
$1,805.99

Dollar Difference

$901,103.20

$332,302.16

$568,801.04

Staff Training and Education Days:
80 CSU staff x $100/hr (including overtime hours) x 4 hours Education/Training:
=$32,000 total

Return of Investment Calculation:
CPPD days in CVICU- CPPD from utilizing CSU bed - Cost of Training:
Net Savings: = $901,103.20-$332,302.16-$32,000
=$536,801.04
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Appendix F
PDSA Cycle
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Appendix G
Process Map of the TF TAVR Transfer Workflow

48

RESTRUCTURING THE TRANSFER WORKFLOW

49

Appendix H
Measurement Tools
Figure 1: Number of the TF TAVR procedure. The discharge goal for POD #1 is set at 40%.
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TF TAVR Summary of Patient Procedure and
Discharge
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Figure 2: A line graph showing six months of the progress of the TF TAVR clinical pathway
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Six Months Discharge Trend of TF TAVR
following Clinical Pathway
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